Aerovance is a spin out biotechnology company formed from Bayer’s Berkeley, California-based Biologics unit. The mission of the Company is to develop and commercialize recombinant proteins for severe respiratory and inflammatory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease.